Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Winston Medical Supply Co., Ltd. (6817:TWSE), powered by AI.
Winston Medical Supply Co., Ltd. is currently trading at $60.20. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Winston Medical Supply Co., Ltd. on Alpha Lenz.
View Winston Medical Supply Co., Ltd.'s valuation metrics on Alpha Lenz.
“Winston Medical Supply Co., Ltd.'s ROE is 27.1%. Explore profitability and growth together.”
Ask for details →Winston Medical Supply Co., Ltd. is a healthcare company specializing in the development, manufacturing, and distribution of pharmaceuticals, nutritional supplements, and cosmeceuticals. Established in 1974 and based in Tainan City, Taiwan, the company serves both domestic and international markets. Its product portfolio includes sterile ophthalmic preparations such as gels, suspensions, solutions, and emulsions; hormone-based treatments targeting birth control and cancer cachexia; external-use ointments; and a variety of oral preparations like powders, tablets, capsules, and chewables for treating colds and gastrointestinal conditions. Winston Medical Supply also produces generic drugs, eye drops, and medical beauty products, with capabilities extending to OEM manufacturing services. The company plays a notable role in Taiwan’s pharmaceutical and medical research sector, contributing to healthcare accessibility through its wide range of specialty and generic drug offerings. With over 180 employees, Winston Medical Supply Co., Ltd. maintains its relevance in the healthcare industry by focusing on scientifically-backed products and expanding its reach beyond Taiwan through export activities.
“Winston Medical Supply Co., Ltd.'s ROE is 27.1%. Explore profitability and growth together.”
Ask for details →Winston Medical Supply Co., Ltd. (ticker: 6817) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
The current price is 60.2 with a P/E ratio of -x and P/B of -x.
ROE is 27.06% and operating margin is 20.26%. Annual revenue is $700M.